Profil
Erik Bergman formerly worked at Kibion AB, as Acting Chief Executive Officer, Senzime AB, as Chief Financial Officer & Executive Vice President from 2019 to 2022, Novavax AB, as Chief Financial Officer from 2010 to 2013, and Orexo AB, as Chief Financial Officer.
Ehemalige bekannte Positionen von Erik Bergman
Unternehmen | Position | Ende |
---|---|---|
SENZIME AB | Finanzdirektor/CFO | 01.01.2022 |
Kibion AB
Kibion AB Medical SpecialtiesHealth Technology Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden. | Präsident | 15.11.2010 |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Finanzdirektor/CFO | - |
OREXO AB | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
OREXO AB | Health Technology |
SENZIME AB | Health Technology |
Private Unternehmen | 2 |
---|---|
Kibion AB
Kibion AB Medical SpecialtiesHealth Technology Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden. | Health Technology |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |